# Cipla, Ltd. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/cipla-ltd/f726d9c8-4fe7-456e-848c-f9ef86f00e4f

> Inspection records and compliance data for Cipla, Ltd. in Kurkumbh Village, Dist. Pune, None. Access full analysis and detailed observations.

---

## Details

- Name: Cipla, Ltd.
- FEI Number: 3002806702
- City: Kurkumbh Village, Dist. Pune
- State: None
- Country Name: India
- Address Line 1: Plots D-7, D-22, D-27, M.I.D.C. Industrial Area, Taluka-Daund
- Zip Code: None
- Facility Type: Pharmaceutical Manufacturer
- Business Operations: API MANUFACTURE, FDF MANUFACTURE

## Related Documents

- [483 - Cipla, Ltd. - 2024-05-08](https://www.globalkeysolutions.net/records/483/cipla-ltd/49e75f7a-9d48-4aab-b5d8-fcdacd62e11c) — source: FDA, date: May 8, 2024
- [FDA Inspection 1236690 - Cipla, Ltd. - 2024-05-08](https://www.globalkeysolutions.net/records/fda_inspections/cipla-ltd/e8c6d844-b9ae-42ca-a552-6ba48bff0d1b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 8, 2024
- [483 - Cipla, Ltd. - 2024-05-06](https://www.globalkeysolutions.net/records/483/cipla-ltd/7c8e1395-291d-4698-ad4d-88a7bde50b11) — source: FDA, date: May 6, 2024
- [483 - Cipla, Ltd. - 2019-03-20](https://www.globalkeysolutions.net/records/483/cipla-ltd/4f536fa1-9193-4e02-8c65-9f726b4bc1da) — source: FDA, date: March 20, 2019
- [FDA Inspection 1084973 - Cipla, Ltd. - 2019-03-20](https://www.globalkeysolutions.net/records/fda_inspections/cipla-ltd/764f7c2a-e451-45ce-b59f-335b801752d6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 20, 2019
- [483 - Cipla, Ltd. - 2018-11-30](https://www.globalkeysolutions.net/records/483/cipla-ltd/073508e0-bb26-49d8-a957-16fbe67ca9f6) — source: FDA, date: November 30, 2018
- [483 - Cipla, Ltd. - 2018-11-30](https://www.globalkeysolutions.net/records/483/cipla-ltd/c2182f72-76c8-4eda-b528-fd5f65155e44) — source: FDA, date: November 30, 2018
- [FDA Inspection 1073182 - Cipla, Ltd. - 2018-11-30](https://www.globalkeysolutions.net/records/fda_inspections/cipla-ltd/b1027033-f7b0-45cd-988a-1c6498b1ba37) — classification: No Action Indicated (NAI), source: FDA, date: November 30, 2018
- [FDA Inspection 997481 - Cipla, Ltd. - 2016-12-09](https://www.globalkeysolutions.net/records/fda_inspections/cipla-ltd/0150dc7b-0ea7-4467-9129-865c909e274d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 9, 2016
- [FDA Inspection 882706 - Cipla, Ltd. - 2014-05-23](https://www.globalkeysolutions.net/records/fda_inspections/cipla-ltd/c7f2a5d8-d507-4b98-8b06-73cc42214c50) — classification: No Action Indicated (NAI), source: FDA, date: May 23, 2014
- [FDA Inspection 755727 - Cipla, Ltd. - 2011-12-01](https://www.globalkeysolutions.net/records/fda_inspections/cipla-ltd/73f0e27b-f3e5-4233-8f02-6a5701d7436a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 1, 2011
- [FDA Inspection 577340 - Cipla, Ltd. - 2009-03-26](https://www.globalkeysolutions.net/records/fda_inspections/cipla-ltd/df3e6be9-be90-4822-9e1d-4f56e861138d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 26, 2009

## Related Companies

- [Sumitomo Dainippon Pharma Co., Ltd.](https://www.globalkeysolutions.net/companies/sumitomo-dainippon-pharma-co-ltd/40ead027-5fd5-4deb-a37b-40301cffd612)
- [Gland Pharma Limited](https://www.globalkeysolutions.net/companies/gland-pharma-limited/dd730d79-1c97-4fb0-b717-c0ebd71a5b3f)
- [Biological E. Limited](https://www.globalkeysolutions.net/companies/biological-e-limited/a02640a2-3dc0-448e-9a4f-df7e189939e4)
- [Serum Institute of India Pvt. Ltd.](https://www.globalkeysolutions.net/companies/serum-institute-of-india-pvt-ltd/a1288932-02ec-49e6-942a-e8d90c93b890)
- [Boehringer Ingelheim Fremont, Inc.](https://www.globalkeysolutions.net/companies/boehringer-ingelheim-fremont-inc/3d7d0ca7-27cd-4223-8ade-7193417c9861)
- [Sinopep-Allsino Biopharmaceutical Co., Ltd.](https://www.globalkeysolutions.net/companies/sinopep-allsino-biopharmaceutical-co-ltd/f45b83cf-0416-4308-92bf-f7f3212ca356)
- [Bavarian Nordic Berna GmbH](https://www.globalkeysolutions.net/companies/bavarian-nordic-berna-gmbh/c041bdf1-c3d5-46c3-a216-02ad314f45e0)
- [Juno Therapeutics, Inc.](https://www.globalkeysolutions.net/companies/juno-therapeutics-inc/d564709e-29d0-4aaf-9d68-efbf3cd67a35)
- [BioMarin International Limited](https://www.globalkeysolutions.net/companies/biomarin-international-limited/dbd5911b-3dec-4a03-a980-1e45a5f973a4)
- [Lonza Houston, Inc](https://www.globalkeysolutions.net/companies/lonza-houston-inc/c3ae4db9-9aba-4b65-9e2b-06e1632112a6)

## Related Officers

- [Senior Director](https://www.globalkeysolutions.net/people/mangesh-vaze/52aaa0da-4997-4f6d-97d9-f595e8bb95f5)
- [investigator](https://www.globalkeysolutions.net/people/rozelle-g-smith/cd2488c0-fe18-4fc4-a80e-20d08a8d12cc)
- [Vani Mathur Richards](https://www.globalkeysolutions.net/people/vani-mathur-richards/10fd1825-408e-4826-8cee-6d3ba119cc8b)
- [Cheryl A. Clausen](https://www.globalkeysolutions.net/people/cheryl-a-clausen/2306b2bc-8f01-4f77-ba2d-1a3186d6f6fc)